Ryoichi Bessho
Asahikawa, 0788510, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Role of metallothionein 3 in diabetic nephropathy via interplay with HIF-1α.
Journal: Diabetology international
Published: May 14, 2025
Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial.
Journal: Metabolic syndrome and related disorders
Published: October 18, 2024
A maternal high-fat diet induces fetal origins of NASH-HCC in mice.
Journal: Scientific reports
Published: October 01, 2021
A case of insulinoma diagnosed postpartum with hypoglycemic symptoms that were masked during pregnancy.
Journal: Clinical case reports
Published: November 26, 2020
Establishment of novel specific assay for short-form glucose-dependent insulinotropic polypeptide and evaluation of its secretion in nondiabetic subjects.
Journal: Physiological reports
Published: February 24, 2020
Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test.
Journal: BMC endocrine disorders
Published: July 16, 2019
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy.
Journal: Scientific reports
Published: June 07, 2019
Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8.
Journal: EBioMedicine
Published: June 30, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026